MedPath
HSA Approval

AVOXRED POWDER FOR SUSPENSION FOR INJECTION 100MG/VIAL

SIN15875P

AVOXRED POWDER FOR SUSPENSION FOR INJECTION 100MG/VIAL

AVOXRED POWDER FOR SUSPENSION FOR INJECTION 100MG/VIAL

January 16, 2020

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

SUBCUTANEOUS

Medical Information

L01BC07

azacitidine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

DR. REDDY'S LABORATORIES LIMITED

Active Ingredients

Azacitidine

100 mg/ml

Azacitidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.